Carmell Therapeutics Corporation (CTCX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 282,051.6 |
| Enterprise Value | -114,750 |
| P/E Ratio | -0.03 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.11 |
| Price/Book Ratio | -0.04 |
| Enterprise/Revenue | 0.27 |
| Enterprise/EBITDA | -0.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -4.05 |
| Operating Margin | -3.58 |
| Return On Assets | -6.47 |
| Return On Equity | 1.07 |
| Revenue | 1.91M |
| Revenue/Share | 0.68 |
| Gross Profit | 1.09M |
| EBITDA | -6.81M |
| Net Income | -6.91M |
| Diluted EPS | -4.83 |
| Total Cash | 35,471 |
| Total Cash/Share | 0.01 |
| Total Debt | 260,647 |
| Total Debt/Equity | -0.04 |
| Current Ratio | 0.07 |
| Book Value Per Share | -3.51 |
| 52-Week Change | -92.69 |
| 52-Week High | 3 |
| 52-Week Low | 0.17 |
| Moving Average 50 Days | 0.35 |
| Moving Average 200 Days | 0.63 |
| Average Volume | 8.24M |
| Shares Outstanding | 30.12M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |